Articles
Ernst & Young exec touts 'inevitable' biotech boom
There's at least one respected member of the investment community who believes the biotech boom is around the corner. Despite the complications that have surrounded the birth of the international biotechnology industry, Leslie Platt, a biotech investment expert with the international accountancy firm Ernst and Young, is irrepressibly bullish about its future. [ + ]
Proteomics at your service
The service centre model for proteomics has taken off in the last few years. Iain Scott looks at some of the groups around Australia who are staking out their claims in this area. [ + ]
Building on the foundations
Other states may have more surface glitz and glamour, but many local experts agree NSW has the makings of a solid, healthy and expanding biotech industry. Jeremy Torr investigates. [ + ]
New potential unleashed for microarrays
With the 3rd Australian Microarray Conference just around the corner, Jeremy Torr takes a look at what's new in the technology. [ + ]
Queensland bio braces for the future
Thanks to a massive infrastructure funding boost from a government led by bio-enthusiast Premier Peter Beattie, Queensland got off to a fast start in biotechnology. But, asks Pete Young, is the venture capital bottleneck pushing its plans off track? [ + ]
Automation in the metals laboratory
Laboratories in the metal industry perform a variety of tasks that are closely tied to the production process. X-ray fluorescence and optical emission spectroscopy today are the preferred techniques
[ + ]De novo sequencing of tryptic peptides
De novo sequencing has evolved to become a very useful tool for the complete elucidation of protein primary structures - especially in case of an unknown proteome. In a recent contest, MALDI-TOF/TOF MS has shown its huge potential for this task
[ + ]Four legs good
It doesn't attract the limelight, but Australia's vet biotech sector is making strides, reports Melissa Trudinger [ + ]
Flying the flag for bioinformatics
David Braue discovers why the upcoming ISMB conference in Brisbane is likely to boost the profile of bioinformatics in Australia. [ + ]
Winds of change
As the winds of change whistle through the life sciences industry in Australia and overseas, some bio-IT trends are also changing, a poll of the major vendors reveals. [ + ]
Making IT headlines
Bob Palermini got his first taste of Unix some 25 years ago when he became involved in production at a small newspaper that used the system to set type. Although he started out as an editor, Palermini was hooked on IT after that initial experience and taught himself the skills to make the transition to the technology side of the business. “Early on it was trial and error and books,” he says. [ + ]
The ones to watch
Melissa Trudinger takes a look at the emerging biotech clusters in Perth and Adelaide. [ + ]
Happy together
When it comes to clustering, Australian biotech could take a few lessons from the nation's wine industry -- and not just the grapes, David Binning finds. [ + ]
Nobel laureate Sulston critical of 'greedy' IP
History students and trivia buffs in the distant future time will be grateful for one of history's little coincidences -- the Human Genome Project will be completed this year, 2003, a neat half-century after the elucidation of the structure of DNA. [ + ]
Seller beware: what do buyers of scientific equipment want?
Keeping up with the Joneses has become critical in research, where the race to achieve an important result not only guarantees a high-profile paper, but in the increasingly commercial world can provide an edge over a competing interest. [ + ]